focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Directorate Change

19 Feb 2021 07:01

RNS Number : 6530P
Kingspan Group PLC
19 February 2021
 

 

Kingspan Group Plc

 

Director Appointments

 

19 February 2021

 

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, is pleased to announce the appointments of Éimear Moloney as an Independent Non-Executive Director and Paul Murtagh as a Non-Executive Director with effect from 30 April 2021.

 

Éimear (50) was previously a senior investment manager in Zurich Life Assurance (Irl) plc managing asset allocation and various geographic equity portfolios, and has excellent knowledge and experience of capital markets and asset management. She has a B.A. Accounting and Finance and MSc. Investment and Treasury from Dublin City University. She is a fellow of the Institute of Chartered Accountants in Ireland, and a member of the Institute of Directors in Ireland. Éimear also has strong experience in the pharma manufacturing and controls environment as a non-executive Director of Chanelle Pharmaceuticals Group. Éimear is a non-executive Director on the Boards of Hostelworld Group plc where she chairs the Audit Committee and Yew Grove REIT plc.

 

Paul (47) is the Chairman and CEO of Tibidabo Scientific Industries Ltd, and was formerly the Chairman and CEO of Faxitron Bioptics LLC, leading it to its successful sale in 2018. He was also formerly the Chairman of Deerland Probiotics & Enzymes Inc. He has an excellent understanding of the US market and has significant experience in the global build out of a variety of medical and biotech businesses. Previously he worked in investment banking mergers & acquisitions at Merrill Lynch & Co. in New York and Sydney. He holds a BComm International from University College Dublin, and is a non-executive director of a number of private companies.

 

Neither Éimear Moloney nor Paul Murtagh hold any shares in the Company.

 

There are no disclosures required to be made pursuant to Rules 6.6.7 (2) to (6) of the Listing Rules.

 

 

Lorcan Dowd

Company Secretary

+ 353 (0)42 9698000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABCGDDBGBDGBI

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.